Which clot-busting drug works best for stroke? Two newer options may help more people walk and talk normally again.

Imagine you or a loved one has just had a stroke. In the frantic rush to the hospital, a doctor has to choose which clot-busting drug to give. That single choice could shape your ability to walk, talk, and live independently three months later. A massive review of 21 clinical trials, involving over 16,800 patients, compared all the available drugs given within 4.5 hours of a stroke. The goal was to see which ones help people recover best and which are safest. The findings are striking. Two newer drugs stood out for helping more people achieve an excellent recovery—meaning they could walk and care for themselves with no help. One, called reteplase (given as two 18 mg doses), was better than the standard drug alteplase at helping patients get back to normal. Another, a new version of staphylokinase, showed an even stronger benefit for excellent recovery. On safety, this new staphylokinase also appeared to carry a lower risk of a dangerous brain bleed than one dose of another newer drug, tenecteplase. Importantly, none of the drugs showed a difference in the risk of dying within 90 days. The bottom line is clear: in the race against time after a stroke, the specific medication used is a critical factor for a good outcome.